Clinical Trial

Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2024 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-01-26; most recent amendment 2024-01-27.
Status change: Not Yet Recruiting → Recruiting 2019-02-26
Trial Details
NCT Number NCT03414827
Lead Sponsor Zealand University Hospital
Conditions Kidney Cancer
Enrollment 120 participants
Start Date 2019-02-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-01-30